Immix Biopharma Target Price

See Immix Biopharma's analyst price targets ($23) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$9.68

Average Target Price

$23.33

141% upside

3 analysts in the last 4 months

High: $26 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-15	Mizuho Securities	$26	168.6% upside
2026-08-11	Morgan Stanley	$19	96.3% upside
2026-08-10	H.C. WainwrightRobert Burns	$25	158.3% upside
2026-05-22	H.C. WainwrightRobert Burns	$20	106.6% upside
2026-03-27	H.C. Wainwright	$15	55% upside
2026-02-09	Mizuho SecuritiesGraig Suvannavejh	$14	44.6% upside
2025-12-09	H.C. Wainwright	$12	24% upside
2024-07-01	H.C. WainwrightRobert Burns	$7	27.7% downside

Immix Biopharma (IMMX) FAQ

As of the most recent data, IMMX shows a target price of $23. Scroll down for historical charts and peer comparison views.

If Immix Biopharma moved to the average analyst target of $23, shares would be roughly 141.0% higher than $9.68. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Immix Biopharma's earnings trajectory.

Besides this target price page, Stockcircle has Immix Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $23) with ownership activity and broader fundamentals.